Por: New York Post Opinion December 05, 2022
It’s almost comical the way the liberal media at large falls back on two narratives when confronting stories that hurt Democrats: 1. “This isn’t a story,” “nothing we didn’t know.” 2. Attack the messenger. It happened the first time around with the Hunter Biden laptop story. When about Hunter introducing partners and foreign agents to then-Vice President Joe, who swore up and down he “never discussed” business with his... + full article
RTTNews USA Health December 14, 2022
Genetic medicines company Passage Bio, Inc. () announced on Wednesday new interim safety, biomarker, and clinical development results from cohorts 1-3 in the Imagine-1 clinical study.Imagine-1 is a Phase 1/2, global, open-label, dose-escalation study of the AAVhu68 gene therapy... + más
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
Shiseido’s New Hyaluronic Acid Serum System Is Filler Without The Needle | Forbes
Ars Technica USA Science December 10, 2022
Navigate Filter by topic Settings Front page layout Site theme - Dec 9, 2022 11:08 pm UTC / Reisa Lancaster RN, left, administers the Covid-19 vaccine to 14 month old Ada Hedge, center, being comforted by mom Sarah Close and dad Chinmay Hedge, right at Children's National... + más
FDA greenlights bivalent vaccines for children as young as 6 months old | Politico
New COVID booster authorization will sway parents to get young kids vaccinated, FDA vaccine chief hopes | ABC News
Politico USA Health December 08, 2022
The FDA on Thursday authorized emergency use of updated bivalent Covid-19 vaccines for children as young as 6 months old. The move to authorize bivalent shots made by Pfizer-BioNTech and Moderna comes as Covid-19 infections in the United States tick up amid the most intense flu... + más
Kids 5-11 can now get the bivalent, BA.5-targeting COVID booster | Ars Technica
FDA authorizes bivalent COVID-19 boosters for children as young as 6 months | WGN-TV
RTTNews USA Health December 05, 2022
Nkarta Inc. () is scheduled to report updated clinical data from its ongoing clinical trial of NKX019, its CD19-directed CAR NK cell therapy candidate, today, December 5.The company is developing allogeneic engineered natural killer (NK) cell therapies to treat cancer.NKX019 is... + más
Nkarta Says FDA Clears IND Application For NKX019 To Treat Lupus Nephritis | RTTNews
Slate USA Politics November 09, 2022
This post is part of Slate’s Election Day questionnaire, where we ask reporters to chat about topics they’ve been covering through the midterm campaign. Natalie Shutler: Let’s talk about money. Jim, you wrote recently about how the Dems put money behind MAGA types? Will it... + más
Unholy: Sam Smith's new song is a TikTok hit | CNN
Sam Smith & Kim Petras' 'Unholy' Reaches No. 1 On Billboard Hot 100 | RTTNews
10 WBNS USA Health September 29, 2022
WASHINGTON — At-risk people who received a single dose of the monkeypox vaccine in U.S. efforts against the virus appeared to be significantly less likely to get sick, public health officials announced Wednesday, even as they urged a second dose for full protection. It was the... + más
A single dose of monkeypox vaccine provides some protection against infection, CDC says | CNBC
HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC
CNBC USA Health September 28, 2022
Los Angeles, CA - August 10: Luis Garcia, a registered nurse, prepares Monkeypox virus vaccine at St.John's Well Child & Family Center on Wednesday, Aug. 10, 2022 in Los Angeles, CA.Irfan Khan Los Angeles Times Getty ImagesPeople at risk for monkeypox who have not received... + más
The First U.S. Data Show the Monkeypox Vaccine Is Effective | Time
About iurex | Privacy Policy | Disclaimer |